Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

NCT04939428 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2441

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease (COVID-19)

Interventions

DRUG: Molnupiravir
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC